When Anita Dunn, until recently the White House communications director, labelled Fox News "the research arm or the communications arm of the Republican Party," she got the power dynamic backward.
When Anita Dunn, until recently the White House communications director, labelled Fox News "the research arm or the communications arm of the Republican Party,'' she got the power dynamic backward.
He also has castigated government efforts to curb "off-label" communications, which involve manufacturers' touting of drugs for purposes for which they haven't been approved.
The proposed powers appear in the draft communications data bill, labelled as a snooper's charter, was announced in 2012 and subjected to widespread criticism and blocked previously by the Liberal Democrats.
The shelved communications data bill – labelled a "snooper's charter" by critics – would have required companies to retain phone and email data to include records of browsing activity, social media use and internet gaming, among other things.
Mike Luftman, the vice president for communications for Time Warner Cable, labeled the Disney position "an extortion demand" and likened Disney's tactics in choosing Houston as the city to fight out the dispute to "terrorists taking hostages and then taking one out and shooting him in the head".
Once a particular communications platform is labeled "common carriage," operators of that platform are prohibited — absent government approval — from making "individualized decisions" about what to say (or "carry") and what not to say (or not "carry").
Osborn refers to WLF's 2004 request that DOJ provide clearer guidance on the investigation of off-label communications cases, and notes how DOJ's response was indicative of the government's determination to keep its approach to off-label matters as unclear and unpredictable as possible.
Prior to his nomination, Gottlieb, a resident fellow at the conservative American Enterprise Institute and a doctor, advocated loosening the restrictions on off-label communications.
The pharmaceutical industry did not formally lobby on behalf of the bill, although it has called for a revision in the FDA policies on communications about off-label uses.
This report is based on a review of the medical literature, available US Food and Drug Administration FDAA) communications and product labels, and a P&T Product Profiler 14 provided by ProStrakan (Bridgewater, NJ, USA).
